title: On the Need for Phase III Studies of Risk-Adapted Therapy in Multiple Myeloma.
authors.affiliation: Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina. Electronic address: Peter.Voorhees@carolinashealthcare.org.
authors.forename: Peter
authors.initials: P
authors.lastname: Voorhees
mesh_terms: D006801:Humans; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000473:pathology / Q000628:therapy; D017326:Clinical Trials, Phase III as Topic